Concerta

Mechanism of Action
Concerta is a brand name for methylphenidate extended-release, a central nervous system (CNS) stimulant. Methylphenidate works by inhibiting the reuptake of dopamine and norepinephrine in the brain. This increases the availability of these neurotransmitters in the synaptic cleft, improving signal transmission in areas of the brain involved in attention, focus, and impulse control. Concerta's extended-release formulation provides a steady release of the medication throughout the day, mimicking a natural circadian rhythm for symptom control.
Clinical Benefits
Concerta is primarily used to treat:
  1. Attention-Deficit/Hyperactivity Disorder (ADHD): Improves core symptoms such as inattention, hyperactivity, and impulsivity. It enhances focus, academic and occupational performance, and social functioning.
  2. Narcolepsy: Reduces excessive daytime sleepiness by promoting wakefulness (off-label).

Dosage
Concerta is available in extended-release tablets with strengths ranging from 18 mg to 72 mg.
Initial Dose: For individuals not previously on methylphenidate, the recommended starting dose is 18 mg once daily, taken in the morning.
Titration: The dose can be increased in 18 mg increments weekly, based on clinical response and tolerability.
Maximum Dose: Typically 72 mg per day, though lower doses may suffice for therapeutic effects.
Tablets must be swallowed whole to ensure proper extended-release function.
Prevalence of Side Effects
Concerta has side effects ranging from mild to severe. The prevalence varies by dose and individual sensitivity.
  • Common Side Effects (10-30%):
    • Insomnia
    • Decreased appetite
    • Headache
    • Stomach pain or nausea
    • Weight loss
    • Increased heart rate or palpitations
  • Less Common Side Effects (1-10%):
    • Irritability
    • Anxiety
    • Sweating
    • Dizziness
    • Blurred vision
  • Rare but Serious Side Effects (<1%):
    • Cardiovascular Events: Hypertension, tachycardia, or, rarely, myocardial infarction or stroke in predisposed individuals.
    • Psychiatric Effects: New-onset or worsening psychosis, mania, or suicidal ideation.
    • Dependency/Abuse Potential: Low risk when used as prescribed but still classified as a Schedule II substance.
Efficacy and Safety
Concerta has shown high efficacy in managing ADHD symptoms, with around 70-80% of patients experiencing significant improvement. Side effects are dose-dependent and tend to lessen over time. Monitoring is required for potential cardiovascular or psychiatric adverse effects, especially in individuals with pre-existing conditions.
Sources
  1. Prescribing Information for Concerta, Janssen Pharmaceuticals.
  2. Cortese S, et al. "Comparative efficacy and tolerability of medications for ADHD: A systematic review and network meta-analysis." The Lancet Psychiatry, 2018.
  3. American Academy of Pediatrics. "ADHD Guidelines." Pediatrics, 2019.